Palestine

Category: 4. Health

  • People with lupus who have certain antibodies are more likely to experience blood clots, researchers find

    People with lupus who have certain antibodies are more likely to experience blood clots, researchers find

    Some patients with lupus who possess specific antibodies are at a higher risk of thrombotic events such as a blood clot, stroke or heart attack, a new study led by Johns Hopkins Medicine researchers shows. The finding might help clinicians determine which patients may need early treatment and clinical monitoring for thrombotic events.

    Normally, antibodies help protect the body by fighting infections and tumors, but in autoimmune conditions such as lupus, antibodies may go after healthy…

    Continue Reading


    News Source: www.sciencedaily.com

  • New insights into the energy balance of brain neurons

    New insights into the energy balance of brain neurons

    A research team at the Carl Ludwig Institute for Physiology at Leipzig University has, for the first time, demonstrated how the energy levels of individual neurons in the brain change during so-called spreading depolarizations — waves of activity that occur in various brain disorders. The findings provide important foundations for understanding energy metabolism in cases of acute cerebral ischaemia, such as that which occurs during a stroke.

    Adenosine triphosphate, or ATP, is an essential…

    Continue Reading


    News Source: www.sciencedaily.com

  • Rediscovering the first known cellular receptor

    Rediscovering the first known cellular receptor

    After earning notoriety as the first cellular receptor isolated and mammalian lectin identified, the Ashwell-Morell receptor’s functions in our bodies eluded scientists for more than 30 years.

    In 2008, scientists in San Diego shed new light on this landmark liver cell receptor by identifying its roles in sepsis. Those experiments revealed that the Ashwell-Morell receptor’s binding partners — known as ligands — modulated blood clotting in determining host survival of sepsis.

    “It’s an…

    Continue Reading


    News Source: www.sciencedaily.com

  • Epic Faces Mounting Antitrust Allegations Even As It Grows

    Epic Faces Mounting Antitrust Allegations Even As It Grows

    Epic Systems is perhaps the most successful health technology company in the world. Its electronic health record (EHR) platform is now used by the majority of large health systems in the U.S. Its customers are vocal in their support and are often passionate defenders of the platform’s reliability, configurability, and comprehensiveness….

    Continue Reading


    News Source: www.forbes.com

  • Vision loss, damage could be tied to eye pressure, study finds

    Vision loss, damage could be tied to eye pressure, study finds

    One of the world’s leading causes of irreversible vision loss could begin with elevated eye pressure, according to a recent study published in the American Academy of Ophthalmology.

    Yi Hua, a biomedical engineering professor at the University of Mississippi, partnered with researchers at the University of Pittsburgh to study how ocular hypertension — elevated eye pressure — affects the eye.

    “We wanted to see how intraocular pressure changes and deforms the blood vessels in the eye,” Hua…

    Continue Reading


    News Source: www.sciencedaily.com

  • Marsupial research reveals how mammalian embryos form

    Marsupial research reveals how mammalian embryos form

    Researchers at the Francis Crick Institute have revealed insight into why embryos erase a key epigenetic mark during early development, suggesting this may have evolved to help form a placenta.

    Epigenetic changes are modifications to DNA that don’t change the underlying DNA sequence, like notes written on a recipe. They keep gene expression in check, affecting which genes are turned on or off.

    A universally inherited epigenetic change among mammals, called DNA methylation, is wiped from the…

    Continue Reading


    News Source: www.sciencedaily.com

  • Research shows how hormone can reverse fatty liver disease in mice

    Research shows how hormone can reverse fatty liver disease in mice

    A pioneering research study published today in Cell Metabolism details how the hormone FGF21 (fibroblast growth factor 21) can reverse the effects of fatty liver disease in mice. The hormone works primarily by signaling the brain to improve liver function.

    University of Oklahoma researcher Matthew Potthoff, Ph.D., is the lead author of the study, which provides valuable insight about the mechanism of action of the hormone, which is a target for a new class of highly anticipated drugs that…

    Continue Reading


    News Source: www.sciencedaily.com

  • Could a mini-stroke leave lasting fatigue?

    Could a mini-stroke leave lasting fatigue?

    A transient ischemic attack, also known as a mini-stroke, is typically defined as a temporary blockage of blood flow to the brain that causes symptoms that go away within a day, but a new study finds that people who have this type of stroke may also have prolonged fatigue lasting up to one year. The study is published on May 14, 2025, online in Neurology®, the medical journal of the American Academy of Neurology (AAN). The study does not prove that mini-strokes cause lasting fatigue; it only…

    Continue Reading


    News Source: www.sciencedaily.com

  • New nanoparticle could make cancer treatment safer, more effective

    New nanoparticle could make cancer treatment safer, more effective

    Researchers have created a new kind of nanoparticle that could make ultrasound-based cancer treatments more effective and safer, while also helping prevent tumors from coming back.

    The study, published in the journal Nano Letters, explores a way to make high-intensity focused ultrasound less harmful to healthy tissues.

    Oregon Health & Science University was the first hospital in Oregon to offer prostate cancer treatment using a robotic-assisted high-intensity focused ultrasound device….

    Continue Reading


    News Source: www.sciencedaily.com

  • Duchenne muscular dystrophy gene therapy

    Duchenne muscular dystrophy gene therapy

    To help neurologists, clinicians and families understand the current evidence for a new gene therapy for Duchenne muscular dystrophy called delandistrogene moxeparvovec, the American Academy of Neurology (AAN) has issued an Evidence in Focus article, published May 14, 2025, online in Neurology®.

    AAN Evidence in Focus articles highlight the strength of the current evidence for new therapies for neurological conditions. Their purpose is not to provide recommendations for practice, but rather…

    Continue Reading


    News Source: www.sciencedaily.com